Skip to content

Study on the Efficacy of Staged Sequential Functional Nutrition Therapy in Children with Moderate to Severe Crohn's Disease

Study on the Efficacy of Staged Sequential Functional Nutrition Therapy in Children with Moderate to Severe Crohn's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102576
Enrollment
Unknown
Registered
2025-05-16
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to Severe Crohn's Disease

Interventions

Sequential Nutritional Therapy Group:Sequential Functional Nutrition
Control group:Free diet

Sponsors

Tianjin Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.According to the Chinese Medical Association "Expert consensus on the diagnosis and treatment of inflammatory bowel disease in children", the diagnosis was consistent with CD. 2.Moderate to severe CD, pediatric Crohn's disease activity index (PCDAI) >=30; 3.Active inflammation at enrollment (C-reactive protein > 5g/L, or erythrocyte sedimentation rate > 20mm/h, or calprotectin > 200µg/g); 4.Parents voluntarily participated and signed informed consent; 5.The patients were treated according to the "Expert consensus on the diagnosis and treatment of inflammatory bowel disease in children" and the clinical pathway of CD in our hospital.

Exclusion criteria

Exclusion criteria: 1.Children with other intestinal diseases or intestinal trauma; 2.in the respiratory tract, digestive tract and other infection period or cured within 1 month; 3.use of probiotics/fecal microbiota transplantation or drug withdrawal within 1 month.

Design outcomes

Primary

MeasureTime frame
Clinical remission rate;

Secondary

MeasureTime frame
Cytokines: CRP, ESR, CALPR, TNF-a, IL-1ß, IL-6, IL-8, IL-10, IL-12, IL-17, IL-22, IFN-?, I-FABP, D-LAC, LPS, DAO, T cell subgroups;

Countries

China

Contacts

Public ContactYing Lin

Tianjin Children Hospital

yinglin@alu.scu.edu.cn+86 22 87787861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026